Apac Medical Aesthetics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 9,744.43 |
 CAGR |
% |
| Major Markets Players |
>亚太医学美学市场，按产品类型（美容激光设备、能量设备、身体塑形设备、面部美容设备、美容植入物和皮肤美容设备）、应用（抗衰老和皱纹、面部和皮肤年轻化、丰胸、塑身和橘皮组织、纹身去除、血管病变、烧灼、色素病变、重建、牛皮癣、白癜风等）、最终用户（美容中心、皮肤科诊所、医院、医疗水疗中心和美容中心）、分销渠道（直接招标和零售销售）划分 - 行业趋势和预测到 2030 年。
亚太医学美容市场分析及规模
亚太地区医疗美容市场比较分散，因为该市场由许多亚太地区公司组成，例如 ALLERGAN、Bausch Health Companies Inc.、Lumenis、上海复星医药（集团）有限公司、Cynosure、Cutera 和 Mentor Worldwide LLC 等。这些公司的存在为整个地区的医疗美容产品提供了具有竞争力的价格。由于这些公司在地区和国际层面的存在，供应商和制造商提供具有不同规格和特点的产品，适合所有预算。技术进步的不断进步正在推动市场增长。此外，主要市场参与者的战略举措预计将推动市场增长。
Data Bridge Market Research 分析称，到 2030 年，亚太地区医疗美容市场预计将达到 97.4443 亿美元的价值，预测期内的复合年增长率为 13.7%。本市场报告还深入介绍了定价分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品类型（美容激光设备、能量设备、身体塑形设备、面部美容设备、美容植入物和皮肤美容设备）、应用（抗衰老和皱纹、面部和皮肤嫩肤、丰胸、塑身和消脂、纹身去除、血管病变、疤痕、色素病变、重建、牛皮癣、白癜风等）、最终用户（美容中心、皮肤科诊所、医院、医疗水疗中心和美容中心）、分销渠道（直接招标和零售销售） |
|
覆盖国家 |
日本、印度、中国、韩国、澳大利亚、泰国、新加坡、马来西亚、印度尼西亚、菲律宾、亚太地区其他地区 |
|
涵盖的市场参与者 |
Allergan、Bausch Health Companies Inc.、Lumenis、上海复星医药（集团）股份有限公司、Syneron Medical Ltd、BTL、Cutera、Eclipse、Lutronic、Mentor Worldwide LLC、Merz Pharma、Sciton Inc.、Sharplight Technologies Inc、Syneron Medical Ltd.、Venus Concept 等 |
市场定义
美容设备是一项创新的进步，为患者提供创造美丽的独创性解决方案。医疗美容设备是一个不断增长的市场，因为它具有诸多好处，例如保持年轻的外表、无痛、非侵入性美容治疗、无需剃须、打蜡或令人不快的毛发护理即可保持光滑无毛的免维护皮肤、改善外观以及医疗美容设备的技术进步。
医疗美容设备是一种美容治疗，通过治疗痤疮、多余毛发、皱纹、晒斑等病症来改善外貌。其好处包括改善外貌、改善健康、即时和持久的效果、增强自尊心等。
亚太医学美容市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
司机
亚太地区人口老龄化
老年人接受整形手术的唯一目的是通过改善或改变他们的身体形象来改善心理健康。重塑正常的身体结构以实现这一目标。整形手术成功地改善了老年人的生活质量指数，减少了抑郁症。亚太地区老年人口的增长带动了医疗美容市场的增长。近年来，美容行业出现了巨大的增长，而老年人口是这一过程的驱动因素之一。大众媒体描绘的完美身材的肤浅目标是其增长的主要原因。人们对看起来更年轻的执着导致了美容市场的各种突破。
技术进步
亚太地区医学美容市场蓬勃发展，得益于潜在客户的认知。追求完美身材和塑造人体的动力推动着美容市场以创新技术进步发展。美容市场本身已经能够吸引亚太地区大量客户。医学美容重新定义了完美的定义。随着技术进步的增加，副作用减少，治疗质量提高。这与人们认知度的提高一起推动了亚太地区医学美容市场的发展。
机会
迫在眉睫的健康革命
过去十年，印度、巴西、南非、泰国等许多发展中国家的生活水平都有所提高。人们选择不同的美容手术来保持自己的身材，这样既能获得更好的效果，又不需要付出巨大的体力。亚太地区的医疗美容市场在许多国家仍未得到开发，但新兴国家对医疗美容的认识不断提高，推动了该市场进一步增长。
克制/挑战
监管情景
每家医疗美容公司，无论规模大小或覆盖哪个市场，都必须遵守监管要求。医疗美容受到严格的政府监管。医疗美容设备和产品的制造商必须经过各种测试才能获得最终验证。遵守 FDA 的标准需要专业技能、资源、时间和金钱。根据《联邦食品、药品和化妆品法案》（FFDC）及其规定，医疗美容必须经过上市前批准申请（PMA）。
后新冠疫情对亚太地区医疗美容市场的影响
由于亚太制造业、物流运输部门停工以及缺乏产品检测，COVID-19 对亚太医疗美容市场产生了负面影响。
COVID-19 疫情在一定程度上对市场产生了负面影响。然而，政府支持的增加和持续的技术进步预计将为市场增长提供丰厚的机会。此外，市场参与者之间日益增多的伙伴关系、收购和协作以及该地区对医学美容产品的认识不断提高，预计将进一步推动市场增长。此外，自 COVID-19 疫情后市场开放以来，增长一直很高，预计该行业将有相当大的增长。市场参与者正在进行多项研发活动，以改进产品所涉及的技术。通过这种方式，公司将为市场带来进步和创新。
最新动态
- 2022年2月，艾尔建（AbbVie Inc. 的子公司）宣布 FDA 批准 JUVÉDERM VOLBELLA XC 用于改善21岁以上成年人的眶下凹陷。此举有助于该公司扩大其在美国市场的美容产品组合。
- 2022 年 1 月，Mentor Worldwide LLC（强生医疗器械公司旗下子公司）宣布，FDA 已批准 MENTOR MemoryGel BOOST 乳房植入物用于隆胸和乳房重建。该产品帮助该公司扩大了其在美国市场的美容产品组合。
亚太医学美容市场范围
亚太医疗美容市场根据产品类型、应用、最终用户和分销渠道分为四个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和见解，帮助他们做出战略决策，确定核心市场应用。
按产品类型
- 美容激光设备
- 能源设备
- 身体塑形设备
- 面部美容仪器
- 美容植入
- 皮肤美容仪器
根据产品类型，市场分为美容激光设备、能量设备、身体塑形设备、面部美容设备、美容植入物和皮肤美容设备。
按应用
- 抗衰老和抗皱纹
- 面部及皮肤年轻化
- 丰胸
- 塑身和消脂
- 去除纹身
- 血管病变
- Sears，色素病变重建
- 牛皮癣和白癜风
- 其他的
根据应用，市场细分为抗衰老和皱纹、面部和皮肤年轻化、丰胸、塑身和脂肪团、纹身去除、血管病变、烧灼、色素病变、重建、牛皮癣和白癜风等。
按最终用户
- 美容中心
- 皮肤科诊所
- 医院
- 医疗水疗中心和美容中心
根据最终用户，市场分为美容中心、皮肤病诊所、医院、医疗水疗中心和美容中心。
按分销渠道
- 直接招标
- 零售销售
根据分销渠道，市场分为直接招标和零售销售。
亚太医学美学市场区域分析/见解
对亚太医学美容市场进行了分析，并按国家、产品类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
本市场报告涵盖的国家包括日本、印度、中国、韩国、澳大利亚、泰国、新加坡、马来西亚、印度尼西亚、菲律宾和亚太其他地区。
预计日本将以最大的市场份额占据市场主导地位。这一份额归因于 Allergan、Bausch Health Companies Inc. 和 Lumenis 等主要市场参与者的存在。预计主要市场参与者的战略举措和新技术的渗透将在预测期内推动该国市场的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
亚太地区医疗美容市场竞争格局及市场份额分析
亚太医疗美容市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
亚太医学美容市场的一些主要市场参与者包括 Allergan、Bausch Health Companies Inc.、Lumenis、上海复星医药（集团）股份有限公司、Syneron Medical Ltd、BTL、Cutera、Lutronic、Mentor Worldwide LLC 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 CUSTOMISED DATA:
4.3.1 INTRODUCTION
5 ASIA PACIFIC MEDICAL AESTHETICS MARKET, REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 AGING POPULATION ASIA PACIFICLY
6.1.2 TECHNOLOGICAL ADVANCEMENTS
6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATORY POLICIES
6.2.2 HIGH COST FOR THE TREATMENTS.
6.3 OPPORTUNITIES
6.3.1 IMMENT HEALTH REVOLUTION
6.3.2 GROWING MEDICAL TOURISM IN ASIA
6.4 CHALLENGE
6.4.1 INCREASING COMPETITORS
7 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 AESTHETIC LASER DEVICES
7.2.1 ABLATIVE SKIN RESURFACING DEVICES
7.2.1.1 CO2 LASER
7.2.1.2 ERBIUM LASER
7.2.1.3 OTHERS
7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES
7.2.2.1 RADIOFREQUENCY
7.2.2.2 INTENSE PULSED LIGHT
7.2.2.3 FRACTIONAL LASER
7.2.2.4 THE Q-SWITCHED ND:YAG LASER
7.2.2.5 OTHERS
7.3 ENERGY DEVICES
7.3.1 LASER SURGERY DEVICES
7.3.2 ELECTROCAUTERY DEVICES
7.3.3 ELECTROSURGERY DEVICES
7.3.4 CRYOSURGERY DEVICES
7.3.5 HARMONIC SCALPEL
7.3.6 MICROWAVE DEVICES
7.4 BODY CONTOURING DEVICES
7.4.1 LIPOSUCTION
7.4.2 NONSURGICAL SKIN TIGHTENING
7.4.3 CELLULITE TREATMENT
7.5 FACIAL AESTHETIC DEVICES
7.5.1 BOTOX INJECTION
7.5.2 DERMAL FILLERS
7.5.2.1 NATURAL DERMAL FILLERS
7.5.2.2 SYNTHETIC DERMAL FILLERS
7.5.3 COLLAGEN INJECTIONS
7.5.4 CHEMICAL PEEL
7.5.5 FACIAL TONING
7.5.6 FRAXEL
7.5.7 COSMETIC ACUPUNCTURE
7.5.8 ELECTROTHERAPY
7.5.9 MICRODERMABRASION
7.5.10 PERMANENT MAKEUP
7.6 AESTHETIC IMPLANTS
7.6.1 BREAST AUGMENTATION
7.6.1.1 SALINE IMPLANTS
7.6.1.2 SILICON IMPLANTS
7.6.2 BUTTOCK AUGMENTATION
7.6.3 AESTHETIC DENTAL IMPLANTS
7.6.3.1 DENTAL TITANIUM IMPLANTS
7.6.3.2 DENTAL ZERCONIUM IMPLANTS
7.6.4 FACIAL IMPLANTS
7.6.5 SOFT TISSUE IMPLANTS
7.6.6 TRANSDERMAL IMPLANT
7.6.7 OTHERS
7.7 SKIN AESTHETIC DEVICES
7.7.1 LASER SKIN RESURFACING DEVICES
7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES
7.7.3 LIGHT THERAPY DEVICES
7.7.4 TATTOO REMOVAL DEVICES
7.7.5 MICRO-NEEDLING PRODUCTS
7.7.6 THREAD LIFT PRODUCTS
7.7.7 NAIL TREATMENT LASER DEVICES
7.7.8 OTHERS
8 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ANTI-AGING AND WRINKLES
8.3 FACIAL AND SKIN REJUVENATION
8.4 BREAST ENHANCEMENT
8.5 BODY SHAPING AND CELLULITE
8.6 TATTOO REMOVAL
8.7 VASCULAR LESIONS
8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE
8.8 PSORIASIS AND VITILIGO
8.9 OTHERS
9 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER
9.1 OVERVIEW
9.2 COSMETIC CENTERS
9.3 DERMATOLOGY CLINICS
9.4 HOSPITALS
9.5 MEDICAL SPAS AND BEAUTY CENTERS
10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 RETAIL
11 ASIA PACIFIC MEDICAL AESTHETIC DEVICES MARKET, BY REGION
11.1 ASIA PACIFIC
11.1.1 CHINA
11.1.2 INDIA
11.1.3 JAPAN
11.1.4 SOUTH KOREA
11.1.5 SINGAPORE
11.1.6 THAILAND
11.1.7 MALAYSIA
11.1.8 INDONESIA
11.1.9 AUSTRALIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 COMPANY PROFILE
13.1 ALLERGAN
13.1.1 COMPANY SNAPSHOT
13.1.2 SWOT ANALYSIS
13.1.3 REVENUE ANALYSIS
13.1.4 COMPANY SHARE ANALYSIS
13.1.5 PRODUCT PORTFOLIO
13.1.6 RECENT DEVELOPMENTS
13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.2 BAUSCH HEALTH COMPANIES INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 SWOT ANALYSIS
13.2.3 REVENUE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.3 LUMENIS
13.3.1 COMPANY SNAPSHOT
13.3.2 SWOT ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD.
13.4.1 COMPANY SNAPSHOT
13.4.2 SWOT ANALYSIS
13.4.3 REVENUE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.5 CYNOSURE
13.5.1 COMPANY SNAPSHOT
13.5.2 SWOT ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.6 AEROLASE CORP.
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 A.R.C. LASER GMBH
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 ASCLEPION LASER TECHNOLOGIES GMBH
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 BTL
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 CUTERA
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 COMPANY SHARE ANALYSIS
13.10.4 PRODUCT PORTFOLIO
13.10.5 RECENT DEVELOPMENTS
13.11 ECLIPSE
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 LUTRONIC
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 MENTOR WORLDWIDE LLC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 COMPANY SHARE ANALYSIS
13.13.4 PRODUCT PORTFOLIO
13.13.5 RECENT DEVELOPMENT
13.14 MERZ PHARMA
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
13.15 QUANTA SYSTEM
13.15.1 COMPANY SNAPSHOT
13.15.2 PRODUCT PORTFOLIO
13.15.3 RECENT DEVELOPMENTS
13.16 SCITON INC.
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENTS
13.17 SHARPLIGHT TECHNOLOGIES INC
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENT
13.18 SYNERON MEDICAL LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 VENUS CONCEPT
13.19.1 COMPANY SNAPSHOT
13.19.2 PRODUCT PORTFOLIO
13.19.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF WORLDWIDE SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020
TABLE 2 NUMBER OF WORLDWIDE NON-SURGICAL PROCEDURES PERFORMED BY PLASTIC SURGEONS IN 2020
TABLE 3 IN 2020, THE TOTAL NUMBER OF SURGICAL PROCEDURES IN RUSSIA WAS 478,200.
TABLE 4 IN 2020, THE TOTAL NUMBER OF NON-SURGICAL PROCEDURES IN RUSSIA WAS 143,400.
TABLE 5 REGULATORY AUTHORITIES FOR MEDICAL AESTHETICS
TABLE 6 COST OF TREATMENT IN VARIOUS COUNTRIES
TABLE 7 THE FOLLOWING TABLE SHOWS THE TOTAL NUMBER OF PLASTIC SURGERIES OCCURRED IN DIFFERENT COUNTRIES:
TABLE 8 THE BELOW TABLE SHOWS THE AVERAGE SAVINGS ON THE TREATMENT AS COMPARED TO U.S.
TABLE 9 TABLE OF COST COMPARISON OF THE TREATMENT IN U.S. AND SHANGHAI
TABLE 10 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC AESTHETIC LASER DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC NON-ABLATIVE RESURFACING DEVICES IN AESTHETIC LASER MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC ENERGY DEVICES IN MEDICAL AESTHETIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC BODY CONTOURING DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC FACIAL AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC DERMAL FILLERS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC AESTHETIC IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC BREAST AUGMENTATION IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC AESTHETIC DENTAL IMPLANTS IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC SKIN AESTHETIC DEVICES IN MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC ANTI-AGING AND WRINKLES IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC FACIAL AND SKIN REJUVENATION IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC BREAST ENHANCEMENT IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC BODY SHAPING AND CELLULITE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC TATTOO REMOVAL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC VASCULAR LESIONS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC SEARS, PIGMENT LESIONS, RECONSTRUCTIVE IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC PSORIASIS AND VITILIGO IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC OTHERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 39 COSMETIC CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC DERMATOLOGY CLINICS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC HOSPITALS IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC MEDICAL SPAS AND BEAUTY CENTERS IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC MEDICAL AESTHETICS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC DIRECT TENDER IN MEDICAL AESTHETICS MARKET, BY REGION , 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC RETAIL IN MEDICAL AESTHETICS MARKET, BY REGION, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC MEDICAL AESTHETICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC MEDICAL AESTHETICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC MEDICAL AESTHETICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC MEDICAL AESTHETICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC MEDICAL AESTHETICS MARKET: SEGMENTATION
FIGURE 10 THE INCREASE IN THE AGING POPULATION ASIA PACIFICLY IS EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL AESTHETICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 11 THE AESTHETIC LASER DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL AESTHETICS MARKET
FIGURE 13 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 14 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 15 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 16 ASIA PACIFIC MEDICAL AESTHETICS MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 17 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2022
FIGURE 18 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 19 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 20 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 21 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2022
FIGURE 22 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 23 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 24 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 26 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 27 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 28 ASIA PACIFIC MEDICAL AESTHETICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: SNAPSHOT (2022)
FIGURE 30 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2022)
FIGURE 31 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 32 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 33 ASIA-PACIFIC MEDICAL AESTHETICS MARKET: BY TEST TYPE (2023-2030)
FIGURE 34 ASIA PACIFIC MEDICAL AESTHETICS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
